• Fighting for Patient Access, Affordability, and Transparency in Health Care
Patients Rising Now
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate
Select Page
  • About
    • Corporate Membership
    • Current Corporate Members
  • Issues
    • News and Insights
    • Position Statements
    • Policy Supported
  • Advocacy Master Class
  • Get Involved
  • Donate

Statement on HHS Proposal to Target Rebates and Pass the Savings on to Patients

Aug 6, 2019 | Medicare Part D, News

Patients Rising Now welcomes the proposed changes by the Trump Administration aiming to lower costs for patients by targeting backdoor rebates and encouraging direct discounts to those who receive their health care through Medicare/Medicaid.    The current drug...
This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

Jul 23, 2019 | Drug Costs, News, Pharmacy Benefit Managers

As the year began, patients seeking relief from high out-of-pocket health care costs had reason to be optimistic. A proposed rule introduced by the Department of Health and Human Services would have stopped pharmacy benefit managers and insurance companies from...

Categories

  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • QALY
  • State Issues
  • Step Therapy
  • Uncategorized
  • Value Frameworks

Tags

340B Biden Administration Cancer chemo drugs cms Copay Accumulators copay assistance COVID-19 Vaccine deferred action DPC drug costs drug discount programs Drug Importation Drug Manufacturing Drug Pricing drug rebate Elizabeth Warren fail first Health Insurance hospital bills HR 3708 hsa ICER Imported Drugs Insurance design Joe Biden Medicaid medicare Part B medicare part D Nonmedical Switching open enrollment out of Out of Pocket Costs Patient Access Patients Assitance PBM pharmacy pharmacy benefit managers Preexisting Conditions Price Transparency Prior Authorization QALY Step Therapy transparency Value Framework

Recent Posts

  • UnitedHealthcare’s Mid-Year Change in Remicade Coverage a Concern for Stable Patients
  • COVID-19 Vaccination: Do States Have a Grip on The Process Yet?
  • Season 2 | Episode 3: When Might You Get the COVID-19 Shot?
  • New Government, Revised Rules? Seniors and Prescription Drug Cost-Sharing
  • S2 | E2: Mystery Hospital Costs 

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.

Patients Rising Now

11710 Plaza America Drive
Suite 200
Reston, VA 20109
  • Privacy Policy
  • Sponsor Opportunities
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now